Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.

Men and women with suspected or proven genital infections caused by Chlamydia trachomatis were enrolled in a double-blind study to evaluate the efficacy and tolerability of fleroxacin. Patients received either 400, 600, or 800 mg once daily for 7 days and were monitored approximately 2, 4, and 7 wee...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bowie, W R, Willetts, V, Megran, D W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2511801/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.10.1774
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!